Skip to main content
OpenTrials

Clinical trial condition

Gastrointestinal Stromal Tumors

Explore clinical trials studying Gastrointestinal Stromal Tumors. Study availability and eligibility vary by location and protocol.

245 public trials 45 recruiting studies
Refine in advanced search Browse all conditions

Gastrointestinal Stromal Tumors trial results

Active, not recruiting

A Study of Ripretinib vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib

NCT03673501

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +6 more
Locations
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • University of California San Diego Medical Center La Jolla, California, United States
  • UCLA Hematology Oncology Center - Main Site Los Angeles, California, United States
  • Stanford Medicine Stanford, California, United States
View all 121 locations
View Trial Details
Active, not recruiting

A Study of Pimitespib in Combination With Imatinib in Patients With GIST (CHAPTER-GIST-101)

NCT05245968

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +6 more
Locations
  • Flinders Medical Center Adelaide, Australia
  • Alfred Health Melbourne, Australia
  • Beijing Cancer Hospital Beijing, China
  • Fudan University, Shanghai Cancer Center Shanghai, China
View all 14 locations
View Trial Details
Active, not recruiting

A Study of Ripretinib vs Sunitinib in Patients With Advanced GIST With Specific KIT Exon Mutations Who Were Previously Treated With Imatinib

NCT05734105

Conditions
Digestive System Diseases, Digestive System Neoplasms, GIST, +7 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Yale University New Haven, Connecticut, United States
  • Mayo Clinic Florida Jacksonville, Florida, United States
  • Sylvester Comprehensive Cancer Center Miami, Florida, United States
View all 70 locations
View Trial Details
Active, not recruiting

SARC044: A Phase II Trial of Bezuclastinib in Combination With Sunitinib in Patients With GIST

NCT06208748

Conditions
Digestive System Diseases, Digestive System Neoplasms, GIST, +8 more
Locations
  • Sylvester Comprehensive Cancer Center, University of Miami Miami, Florida, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Oregon Health & Science University Portland, Oregon, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Study to Allow Access to Imatinib for Patients Who Are on Imatinib Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator

NCT01742299

Conditions
Bone Marrow Diseases, Chronic Disease, Digestive System Diseases, +18 more
Locations
  • University of California LA Los Angeles, California, United States
  • Northwestern University Chicago, Illinois, United States
  • Sidney Kimmel CCC At JH Baltimore, Maryland, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 29 locations
View Trial Details
Completed

Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST)

NCT03556384

Conditions
Brain Diseases, Cancer, Cardiovascular Diseases, +25 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • University of Miami Miami, Florida, United States
  • Oregon Health & Science University Portland, Oregon, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions